Concepedia

Runlan Huo

RH

5

Publications

521

Citations

5

H-Index

2017

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Chongqing University

Runlan Huo is an author at Bristol-Myers Squibb (United States) specializing in health sciences, nanobiotechnology, and redox biology.

Top concepts

Publications per year

2017–2024

5

Publications

5

Engineering of a Nanosized Biocatalyst for Combined Tumor Starvation and Low-Temperature Photothermal Therapy

Jun Zhou, Menghuan Li, Yanhua Hou et al. · ACS Nano · 2018 · 423 citations

, , +20

A Transferrin-Conjugated Hollow Nanoplatform for Redox-Controlled and Targeted Chemotherapy of Tumor with Reduced Inflammatory Reactions

Jun Zhou, Menghuan Li, Wei Qi Lim et al. · Theranostics · 2017 · 58 citations · Full text

A Pilot Study To Assess the Suitability of Riboflavin As a Surrogate Marker of Breast Cancer Resistance Protein in Healthy Participants

Hong Shen, Runlan Huo, Yueping Zhang et al. · Journal of Pharmacology and Experimental Therapeutics · 2024 · 15 citations · Full text

Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein–Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In Vivo

Yueping Zhang, Petia Shipkova, Bethanne M. Warrack et al. · Drug Metabolism and Disposition · 2023 · 14 citations

1β-Hydroxydeoxycholic Acid as an Endogenous Biomarker in Human Plasma for Assessment of CYP3A Clinical Drug–Drug Interaction Potential

Yongjun Xue, Linna Wang, Runlan Huo et al. · Drug Metabolism and Disposition · 2024 · 11 citations

Rows per page

1–5 of 5